About Merz Pharmaceuticals
Merz Pharma Canada Ltd, a wholly owned subsidiary of the Merz Pharma Group of Companies was established in 2009 to commercialize products for Neurology, Dermatology and Aesthetic Medicine.
With a 101 year heritage, Merz (KGaA) is known worldwide for its development of original compounds and formulations for medical professionals and consumers in 90 countries. Globally, Merz is a leader in the development of pharmaceuticals for the treatment of neurological and psychological disorders as well as for aesthetic medicine, including products for the treatment of wrinkles and aging skin, hair loss and acne. Research is concentrated in fields that have a strong need for therapeutic innovation such as Alzheimer's disease, Parkinson's disease, tinnitus, chronic pain conditions, addictions, and neuromuscular disturbances.
The Mederma® family of products, including Mederma® Stretch Marks Therapy, Mederma® Original Scar Gel, Mederma® Advanced Gel and Mederma® PM Intensive Overnight Cream, has a long tradition of efficacy. The #1 doctor- and pharmacist-recommended brand for scars in the United States, Mederma® helps reduce the appearance of scars resulting from surgery, injury, burns, and acne, making them softer, smoother, and less noticeable. Mederma® Stretch Marks Therapy is specifically formulated to reduce the appearance of stretch marks.